Ipropyram Fumarate Tablets
Function and Efficacy
This product activates the pathway that inhibits the release of pain transmitters from the lateral cord, leading to the hyperactivation of intrinsic factor, which inhibits 5-hydroxytryptamine and norepinephrine after binding to the U subtype opioid receptor, thereby eliminating the pain response.
Ingredients
The main ingredient of this product is isopyram fumarate, C16H25N2O.C4H4O4.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| ISOPROPIRAMFUMARATEIngredients |
Activates the pathway that inhibits the release of pain transmitters from the lateral cord, leading to the hyperactivation of intrinsic factor, which binds to the U subtype opioid receptors and inhibits 5-hydroxytryptamine and norepinephrine, thereby eliminating the pain response. More |
84873-04-1 | 2 |
Appearance
This product is white tablets.
Indication
Usage and Dosage
Oral administration, 50-100 mg (1-2 tablets) at a time, 1-2 times a day.
Adverse Reactions
1. May cause stomach discomfort, nausea and cravings. 2. Contraindicated for pregnant and lactating women.
Precautions
1. Pregnant and lactating women are prohibited from using this product. 2. Infants are prohibited from using this product.
Special Population Medication
Precautions for children: It is forbidden for infants. Precautions for pregnancy and lactation: It is forbidden for pregnant and lactating women. Precautions for the elderly: Generally, the physiological functions of elderly patients are low, so the dosage should be reduced (such as 100mg-200mg per day).
Drug Interactions
Not yet clear.
Storage
Keep away from light and store in sealed container.
Packaging Specification
50 mg
Validity Period
Tentative 24 months
Manufacturer
Tonghua Jitong Medical Co., Ltd.
-
Founded in:
2000-06-28 -
Address:
No. 555, Xinming Road, Tonghua City -
Tax NO.:
91220521125495983P -
Registered Funds:
48 million yuan -
Website:
-
Email: